Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT03675958
Eligibility Criteria:
Inclusion Criteria:
* Medical diagnosis of CVD.
* Minimum evolution time from 6 months to 48 months.
* Muscular tone according to the Modified Ashworth Scale\> a 1+ in the elbow and wrist flexors.
* Maintain seated position without human support or assistance for at least 10 seconds and maintain standing position for more than 30 seconds to perform transfers from one surface to another.
Exclusion Criteria:
* Altered cognitive ability, assessed through the "Short Portable Mental State Questionnaire".
* Application of botulinum toxin within six (6) months prior to participation in the study.
* Patients with skin lesions, lacerations or allergies.
* People with pacemaker.
* People in whom the H reflex can not be evoked.
* Pain and hyperalgesia in the upper limb.
* Peripheral vascular disease in upper limb.
* Fractures, or musculoskeletal injuries in the paretic upper limb less than a year old.
* Osteoarthritis, rheumatoid arthritis and clinical conditions associated with acute pain, inflammation, and moderate to severe decrease in joint mobility.
* Consumption of drugs such as Baclofen, benzodiazepines, or muscle relaxants such as dantrolene and tizanidine.
* Ingestion of caffeine and alcohol 12 hours before evaluations.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
70 Years
Study:
NCT03675958
Study Brief:
Protocol Section:
NCT03675958